Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

115.05 +0.29 (+0.25%)
Streaming Delayed Price Updated: 3:45 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
40 41 Next >
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Abbott Laboratories (NYSE:ABT) Shareholder Notice: Lawsuit Alleges Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 09/13/2022 -- An investor, who purchased shares of Abbott Laboratories (NYSE:ABT), filed a lawsuit over alleged Securities Laws violations by Abbott Laboratories in... 
Via SBWire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Dividend Income Update August 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
FDA Approves Abbott's New Spinal Cord Stimulation Device For Pain
Via Benzinga
ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Top Financial Stories Friday, September 09: Elon Musk Hints At Potential Apple-SpaceX Partnership, GM's EV For Cost Conscious Buyers, Google Under DOJ Scanner For Search-Engine Dominance And More...
Bloomberg When The Bank Error Is Not In Your Favor: Pay Back $500 Million 
Via Benzinga
FDA Warns of Clip Lock Malfunctions With Abbott's MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
ABBOTT LABORATORIES SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation – ABT
From The Rosen Law Firm, P.A.
Via Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABT
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Growing Adoption Of This Company's Technologies Could Reportedly Prevent Alcohol Abuse in Workplaces
SOBR Safe Inc. (NASDAQ: SOBR) reports helping to fight a growing alcohol addiction in the workplace. 
Via Benzinga
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
For people suffering from any type of addiction, getting the best medical care can make a significant difference in their journey to recovery. In the case of alcohol abuse, for example, the talk about... 
Via Benzinga
With Alcohol Abuse On The Rise, Could This Company's Virtual and Remote Rehabilitation Program Help?
For centuries, the consumption of alcoholic beverages has played an important social role in many cultures. While it can fuel excitement during personal moments or at gatherings, excessive use can be... 
Via Benzinga
3 Blowout Earnings Reports That Could Mark Turning Points
Based on the market’s reactions, we could someday look back at Q2 earnings as a major inflection point for these three stocks. 
Via MarketBeat
Topics Earnings
Exposures Financial
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Diversification is the edge for any portfolio. Rising inflation is impacting discretionary consumer spending as households try to stretch their wallets. 
Via MarketBeat
Topics Artificial Intelligence Earnings Economy
Exposures Artificial Intelligence Economy Financial
MedTech Giant Abbott To Inject Over €400M In Ireland To Expand Production Of Glucose Monitoring Tech
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today
  Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.78% on an annualized basis producing an average annual return of 13.29%. Currently, Abbott Laboratories has a... 
Via Benzinga
Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Via Benzinga
The 3 Best Vanguard Funds to Buy in August
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months. 
Via InvestorPlace
This Is What Whales Are Betting On Abbott Laboratories
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Is Senseonics (SENS) Stock Heating Up Today?
A big insurer's approval of Senseonomics' Eversense is a big opportunity, but SENS stock still faces scaled competitors. 
Via InvestorPlace
CNBC's Final Trades: Air Products & Chemicals, TJX Companies, Qualcomm And This Healthcare Stock
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management chose Air Products & Chemicals, Inc. (NYSE: APD). 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.